The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A novel analysis of data from the PALOMA-3 trial confirms the efficacy of palbociclib and provides an option for efficacy assessments that could accelerate drug approvals.
 
Celine Yeh
No Relationships to Disclose
 
Mengxi Zhou
No Relationships to Disclose
 
Neil Bapodra
No Relationships to Disclose
 
Maria Rivero
Employment - Pfizer
 
Edward Jose Espinal Dominguez
Employment - Pfizer
 
Marina Moran
Employment - Pfizer
 
Dawn L. Hershman
Consulting or Advisory Role - AIM Specialty Health
 
Antonio Tito Fojo
Honoraria - Merck
Consulting or Advisory Role - Akita Biomedical; ElmediX (I); OnKure (I); PEGASCY (I); SERVIER (I)
Research Funding - Ipsen (Inst); Merck (Inst); Pfizer (I); Pfizer (Inst)
 
Susan Elaine Bates
Honoraria - Merck (I)
Consulting or Advisory Role - Akita Biomedical (I); ElmediX; OnKure; Pegascy; Secura Bio (I); SERVIER
Research Funding - Amgen (Inst); Ipsen (Inst); Merck (Inst); Pfizer; Pfizer (Inst); RenovoRx (Inst)
Patents, Royalties, Other Intellectual Property - Patent: Deacetylase Inhibitor Therapy (Inst); Patent: Depsipeptide for Therapy of Kidney Cancer (Inst)